Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Japanese cases of fibrosing alopecia show a unique age and hair loss pattern, possibly due to racial differences.

Patients with androgenetic alopecia have thinner subcutaneous fat layers in their frontal scalp compared to healthy individuals.

Women with hair loss have more androgen receptors in certain hair follicles.

Trichoscopy helps diagnose hairline recession causes in Egyptian women, with androgenetic alopecia being the most common.

Balding men have harder scalps.

The conclusion is that fat tissue in the skin is a new finding in Frontal fibrosing alopecia and may contribute to hair follicle and muscle degeneration.

Different types of stem cells in the skin contribute to the variety of melanoma forms.

Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.

Androgenetic alopecia in women needs more research and better management strategies.

Certain diets may help with hair growth in people with different types of hair loss.

Women with Frontal Fibrosing Alopecia have more wrinkles near their ears than similar aged women without the condition.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Recognize and treat hair loss conditions that mimic androgenetic alopecia by identifying warning signs and using proper tools.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

Minoxidil was more effective than laser therapy for hair loss, and the report also highlighted the need for more research on PRP for a different hair loss condition, the impact of social media on alopecia views, and a warning on turmeric causing nail discoloration.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Higher DHT in male baldness may protect against prostate cancer.

Men's and women's pattern hair loss progress differently, with men showing more hair thinning and women having more widespread hair loss.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Hair transplant worked for a patient with a specific scalp condition after breast cancer chemotherapy.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Thicker scalp fat may link hair loss with metabolic syndrome.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

New grading scale accurately measures hair loss severity and treatment effectiveness.

Found 32 genes linked to male baldness, affecting hair growth and stress-related pathways.

Women with a certain type of hair loss have more copper in the back of their head than the front, and treatment can normalize hair but not copper levels.

Targeting specific genes in certain pathways may help treat male pattern baldness.